Anthonisen NR - Search Results

1

[Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease].

Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist A, Burge PS, Calverley PM, Connett JE, Lindmark B, Pauwels RA. Sin DD, et al. Among authors: anthonisen nr. Rev Port Pneumol. 2005 Nov-Dec;11(6):603-7. Rev Port Pneumol. 2005. PMID: 16518885 Portuguese. No abstract available.

2

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.

Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, Connett JE, Lindmark B, Pauwels RA, Postma DS, Soriano JB, Szafranski W, Vestbo J. Sin DD, et al. Among authors: anthonisen nr. Thorax. 2005 Dec;60(12):992-7. doi: 10.1136/thx.2005.045385. Epub 2005 Oct 14. Thorax. 2005. PMID: 16227327 Free PMC article.

3

A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.

Soriano JB, Sin DD, Zhang X, Camp PG, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, Connett JE, Petersson S, Postma DS, Szafranski W, Vestbo J. Soriano JB, et al. Among authors: anthonisen nr. Chest. 2007 Mar;131(3):682-689. doi: 10.1378/chest.06-1696. Chest. 2007. PMID: 17356080

4

C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease.

Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. Man SF, et al. Among authors: anthonisen nr. Thorax. 2006 Oct;61(10):849-53. doi: 10.1136/thx.2006.059808. Epub 2006 May 31. Thorax. 2006. PMID: 16738034 Free PMC article.

5

Contemporary management of chronic obstructive pulmonary disease: scientific review.

Sin DD, McAlister FA, Man SF, Anthonisen NR. Sin DD, et al. Among authors: anthonisen nr. JAMA. 2003 Nov 5;290(17):2301-12. doi: 10.1001/jama.290.17.2301. JAMA. 2003. PMID: 14600189 Review.

6

Contemporary management of chronic obstructive pulmonary disease: clinical applications.

Man SF, McAlister FA, Anthonisen NR, Sin DD. Man SF, et al. Among authors: anthonisen nr. JAMA. 2003 Nov 5;290(17):2313-6. doi: 10.1001/jama.290.17.2313. JAMA. 2003. PMID: 14600190

7

Mortality in COPD: Role of comorbidities.

Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Sin DD, et al. Among authors: anthonisen nr. Eur Respir J. 2006 Dec;28(6):1245-57. doi: 10.1183/09031936.00133805. Eur Respir J. 2006. PMID: 17138679 Free article. Review.

8

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

Kanner RE, Anthonisen NR, Connett JE; Lung Health Study Research Group. Kanner RE, et al. Among authors: anthonisen nr. Am J Respir Crit Care Med. 2001 Aug 1;164(3):358-64. doi: 10.1164/ajrccm.164.3.2010017. Am J Respir Crit Care Med. 2001. PMID: 11500333 Clinical Trial.

9

Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?

Man SF, Xing L, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Zhang X, Vessey R, Walker TG, Celli BR, Sin DD. Man SF, et al. Among authors: anthonisen nr. Eur Respir J. 2008 Dec;32(6):1451-7. doi: 10.1183/09031936.00153207. Epub 2008 Sep 17. Eur Respir J. 2008. PMID: 18799503 Free article.

10

Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality.

Hill J, Heslop C, Man SF, Frohlich J, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. Hill J, et al. Among authors: anthonisen nr. Eur Heart J. 2011 Aug;32(15):1918-25. doi: 10.1093/eurheartj/ehr124. Epub 2011 Jun 8. Eur Heart J. 2011. PMID: 21653561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters